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ment of the AMV If an upper limit of normal of 0.5 cm2 is set for the total
area subtended by both leaflets in both views, this criterion is 100% sensitive
and 82% specific forthe diagnosis of MVP. Conclusions: Though TEE demon-
strates greater systolic mitral leaflet displacement in MVP than in NORMAl.
there is overlap in the range of superior systolic displacement of the mi-
tral valve into the left atrium between MVP pts and NORMAL subjects. The
presence of mild superior systolic displacement of the leaflets relative to the
annular hinge points by TEE is inadequate to unambiguously identify MVP
pts.
Accuracy of Aortic Valve Area Measurement by
Multiplane Transesophageal Echocardiography
in Aortic Stenosis
Yvette F. Bernard, Nicolas F. Meneveau, Thierry J. Anguenot, Jian Zhang,
Fran<;ois Schiele, Alain Vuillemenot. Jean-Pierre Bassand. University Hospital
Saint~acques, Besam;on, France
To determine whether planimetry of the aortic valve opening using multi-
plane transesophageal echocardiography (TEE) is accurate, 46 consecutive
patients (ptsl SUffering from calcific aortic stenosis (AS) were enrolled in a
prospective study. All the pts, 26 M, 20 F. aged 67 ± 11 yrs (43 to 81) had a
transthoracic (TIE) and a multiplane TEE using a 5 MHz annular mechanical
probe (Vingmed, Norway), within 24 hours before catheterization (cath.). At
TIE, aortic valve area (AVA) was calculated by the continuity equation (CE).
At TEE, AVA was measured by planimetry of the orifice in a short axis view,
obtained with a 40 to 70' rotation of the imaging plane from the initial plane,
with thorough searching of the smallest orifice as possible in early systole.
Numerical images, recorded on optical disks, were analyzed by 2 indepen-
dent observers unaware of the results of cath. Right and left heart cath. with
measurement of simultaneous left ventricle (LV) to aorta gradients (gr) was
performed in all pts and AVA was calculated using the Gorlin formula. Valve
area measured at TEE and with the CE correlated well with AVA measured
at cath.: r = 0.92 for TEE, p < 0.001 and r = 0.83 for CE, p < 0.01.
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Toward Establishing Anticoagulation GUidelines
for Intravenous Heparin Administration Among
Patients with Myocardiallnfaretion Given Tissue
Plasminogen Activator
Richard Becker, Christopher Cannon, Dorinda George, Joseph Loscalzo, TIMI5
Investigators. Thrombosis Research Center, University of Massachusetts Medical
School, Worcester, MA
Heparin is recommended in patients with acute myocardial infarction (MI)
treated with tPA to prevent early coronary arterial reocclusion. Although prior
clinical studies suggest that an aPTI of at least 1.5 times control is required,
experimental evidence has supported more aggressive degrees of anticoag-
ulation (~3 times control). To date, the benefit and potential risks of agg res-
sive heparin strategies have not been explored fully. In TIMI 5,246 patients
with acute MI received accelerated tPA, oral aspirin and 5 days of either in-
travenous heparin (n = 79) or r-desulfatohirudin (n = 157). Cardiac catheter-
ization was performed at 90 minutes and again at 18 to 36 hours.
Coronary Angiography (18 to 36 hours)
6 hour aPIT 12 hour aPIT 6, 12 hour aPIT
TIMI3 TIMI0,1,2 TIMI3 TIMI0,1,2 TIMI3 TIMI0.1.2
90 Min
Angio
TIMI2.3 74.6 83.9 66.6 77.2 72.9 93.5
TIMI0.1 1075 70.2 90.3
TEE (1) ITE(2) Cath (3) All aPTI's represent median values; no comparison was statistically significant
p < 0.001 for (1) vs 131. p < 0.Q1 for (2) vs 131. p < 0.01 for (1) vs (2), for AVA
Conclusion: Planimetry of the aortic valve using multiplane TEE is accurate
to measure AVA in AS and might be proposed as an alternative to hemody-
namic study in pts with low gradients and poor LV function.
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Major hemorrhage (based on standard TIMI criteria) occurred in 23.3%
of heparin-treated patients. A 12-hour aPTI greater than 75 seconds was
observed in 92% of patients experiencing major hemorrhagic complications.
We conclude that aggressive heparin strategies striving for an aPTI beyond
2.5 times control do not offer additional benefit but are associated with an
increased risk of major hemorrhage.
Brian S. Crenshaw, Richard C. Becker, Christopher B. Granger, Russell P. Tracy,
Costas T. Lambrew, Allan M. Ross, Robert M. Califf, Eric J. Topol. Edwin G. Bovill,
GUSTO Investigators. Duke Medical Center, Durham, NC
Although thrombolytic therapy has been shown to improve survival in the
setting of acute myocardial infarction, failure to reperfuse and reocclusion,
both felt to be mediated in part by thrombin, continue to be significant prob-
lems. To study the impact of heparin on thrombin in thrombolytic treated
patients, we evaluated hematologic parameters after administering strep-
tokinase (SK) in GUSTO patients receiving either immediate IV heparin or
delayed SO heparin. Thrombin generation was estimated by assay for pro-
thrombin fragment 1.2 (F1.2) and thrombin activity by fibrinopeptide A (FpA).
67 patients randomized to SK and IV heparin and 63 patients randomized to
SK and SO heparin were included. IV heparin was given as a 5000 U bolus
followed by 1000-1200 units per hour adjusted to an aPTT of 60-85 seconds,
and SO heparin was given as 12,500 U twice daily beginning 4 hours after
thrombolytic therapy.
Thrombin Activity, but not Generation, is Inhibited
by Intravenous Heparin Following Thrombolysis:
Results from the GUSTO Hemostasis Substudy
FpA (ng/mll and Fl.2 (ng/milleveis increased after starting thrombolytic
therapy among patients treated with SO heparin, in whom steady-state hep-
arin levels do not occur for at least 24 hours. The FpA increase was inhibited
with IV heparin. On the other hand, IV heparin did not inhibit the rise in F1.2
or significantly suppress it below baseline over the course of therapy.
Conclusion: In the first 24 hours following thrombolytic therapy, IV heparin
suppresses the increase in thrombin activity but not the increase in thrombin
generation. Strategies to inhibit factors earlier in the cascade (i.e.. Factors V
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Transesophageal Doppler Analysis of Coronary
Sinus Flow: A New Method to Assess the
Severity of Tricuspid Regurgitation
Jose Zamorano, Carlos Almeria, Fernando Alfonso, Luis Alonso, Vicente Peral,
Luis Sanchez-Harguindey. Hospital Universitario, Madrid, Spain
Our aim was to assess the differences in the Doppler flow pattern of the
coronary sinus (CS) in patients without tricuspid regurgitation (TR) and with
mild (Mil. moderate (Mo) or severe (Se) TR. For this purpose, 35 patients
without TR and 70 patients (mean age 57 ± 8 years, 57% males) with dif-
ferent degrees of TR (27 Mi, 14 Mo, 29 Sel underwent a prospective study
in which the Doppler flow pattern of the CS obtained by transesophageal
echocardiography was analyzed. Adequate Doppler signals of the CS were
obtained in 22 (63%) patients without TR and in 50 (71 %) patients with TR
(18 Mi [65%]. 10 Mo [73%]. 22 Se [75%]). The CS flow was analyzed by TEE
in a transverse plane, showing its drainage into the right atrium, close to the
tricuspid valve.
All patients without TR or with Mi TR showed a typical CS Doppler flow
pattern with 2 waves, a late systolic one and another diastolic with larger
amplitude and velocity. When we analyzed those patients with Se TR, the
late systolic flow became reversed (retrograde) and a Color-Doppler turbu-
lent flow in the CS was found in 96% of them. This reversed systolic wave
(RSyW) was also found in 50% of the patients with Mo TR, all of them with
eccentric regurgitation jets. The sensitivity (SEl. specificity ISP) and diagnos-
tic accuracy iDA) of the presence of a RSyW in the CS for the diagnosis of
severe TR was 95%, 82% and 81 % respectively.
In conclusion, significant TR modifies the CS flow pattern assessed by
transesophageal echocardiography. The presence of a reversed systolic flow
in the CS can be a new sign with good SE, SP and DA in the diagnosis of
severe tricuspid regurgitation.
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The beneficial effect of aspirin (ASA) in unstable angina is well established,
yet data on effect of ASA during the hyperacute phase of myocardial infarc-
tion (AMI) is limited. We evaluated the effect of early chewed ASA adminis-
tration on reperfusion rate and hospital outcome in 90 consecutive AMI pa-
tients treated at home or in the Emergency Room. All patients had ischemic
chest pain of :0:30 minutes, associated with :0:2 mm STt. Early reperfusion
within 30 minutes occurred in 42 patients (46.7%); only 3 patients needed
thrombolysis. In 27 controls reperfusion occurred in 7 patients (25.9%); p
= 0.05. No difference in hospital outcome was observed between patients
with ASA-induced reperfusion and patients treated by thrombolytics.
Conclusion: 1) Chewed ASA taken early in the hyperacute phase of AMI
induced sustained reperfusion in a significant number of patients (46.7%);
2) The above results call for on-scene early administration of chewed ASA in
all suspected AMI patients.
Pawel Buszman, Mariusz GasiDr, Andrzej Wnek, Zbigniew Kalarus,
Stanislaw Pasyk. Silesian Center of Cardiology, Zabrze, Poland
The aim of this study was to assess the influence of pre-hospital treatment
with intravenDus heparin on the early patency rate olthe infarct related artery
in acute myocardial infarction. The inclusion criteria were: beginning of chest
pain in the 6 hDurs preceding admission, ST segment elevation :0: 1 mm in at
least two leads of the standard ECG and no contraindications to antithrom-
botic treatment. One hundred and twenty four patients with these criteria
were divided into 2 groups. Forty five patients (group I) were treated with
5,000 units of heparin Lv. befDre admission tD hospital. Seventy nine patients
(group II) did not receive heparin before hospitalisation. All patients in both
groups were put on Aspirin 150 mg p.o., nitro-glycerine and analgesics be-
fore admission. The mean period from the beginning of the chest pain was
2.7 ± 1.5 hour in group I and 2.8 ± 1.4 hour in group II (p = NS). Both groups
did not differ in relation to age, sex, risk factors and previous incidence of
myocardial infarction. In the emergency room all patients were put on hep-
arin and nitro-glycerine infusions Lv. and were transferred immediately to the
catheterisation laboratory for cDronary angiography. The flow through the in-
farct related artery was assessed according to the TIM I classification. Patent
infarct related arteries (i.e. TIMI flow grade I, 2 or 3) were observed in 19 pa-
tients (42.2%) in group I and in 18 (22.8%) in group II (p = 0.038). Successful
reperfusion (defined as TIMI grade 2 Dr 3) was present in 11 patients (24.4%)
in group I and in 7 (8.8%) in group II (p = 0.035).
.TIMI2,3 CTIMIO,1I
This pilot study suggests that pre-hospital treatment with intravenous hep-
arin can significantly improve flow in infarct related arteries. A prospective
randomised study is needed to confirm these results.
Aspirin-induced Reperfusion in Acute Myocardial
Infarction
Arieh Freifeld, Babeth Rabinowitz, Elieser Kaplinsky, Michal Benderly,
Michael ScheinDwitz, Oren Agranat, Dov Freimark, Hanoch Hod. Heart Institute,
Sheba Medical Center, Tel-Hashomer, Israel
Influence of Pre-Hospital Heparinisation on Early
Patency Rate of Infarct Related Artery in Acute
Myocardial Infarction
We have previously shown that regional myocardial ischemia foliDwed by
reperfusion (rep) significantly enhances cardiac release of the potent vaso-
constrictor endothelin (ET). We now examine the association of ET produc-
tion and myocardial blood flow IMBF) in rabbits (n = 14) undergoing 30 min
Df circumflex occlusion and 3 hrs of rep. MBF was measured with radioac-
tive microspheres at baseline, 15 min into occlusion, 1 min, 1 and 3 hrs into
rep. Utilizing molecular biology techniques, ET1 mRNA was measured at 3
hrs and found to be elevated in the central ischemic zone (CIZ) compared to
the non ischemic zone INIZ). In a second study we investigated the effects
of exogenous ETl and PD145065 (an ETA/B receptor antagonist) on infarct
size of rabbits undergoing 30 min of circumflex occlusion and 48 hrs of rep.
Endothelin ETA/B Receptor Antagonist Reduces
Infarct Size: A Novel Therapy for Acute Myocardial
Infarction
JDaD V. VltDla, JDhn HDlsinger, Menryn B. FDrman, Edwin K. JacksDn,
Masatoshi Kawana, ThDmas QuertermDus, John J. Murray. Vanderbilt University,
Nashville, TN; University of Pittsburgh, Pittsburgh, PA
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0.05 63± -14 (64) 67 ± -18 (69) 62 ± -16 (69) 66±-16 (58)
0.10 81 ± -21 (60) 75 ± -21 (70) 74 ± -19 (59) 72 ± -21 (71)
0.20 83 ± -12 (16) 94 ± -23 (4) 79 ± -16 (18) 73 ± 12 (4)
Total 73 ± -19 (140) 72 ± -21 (143) 69±-19(146) 69 ± -19 (133)
There were no significant differences in aPTT results within dosing groups
or the total patient population for the designated time periods. Conclusion:
Unlike heparin, there does not appear to be a circadian variation in anticoag-
ulant response to hirudin in patients with acute myocardial infarction. This
may contribute to the improved stability in aPTIs observed with hirudin and
has potential clinical importance for both bleeding and thrombotic events.
Is there a Circadian Variation in Anticoagulation
Response to Hirudin Following Acute Myocardial
Infarction?
IX, and XI, by suppressing thrombin generation, may be an important goal
for future management of acute coronary syndromes.
6 hr aPTT (sees)
Timothy D. Henry, Richard C. Becker, Christopher P. Cannon, Carolyn H. McCabe,
Joseph Loscalzo, TIMI5 Investigators. Hennepin County Medical Center,
Minneapolis, MN
There is a well-described circadian variation in the occurrence of acute
thrombotic coronary syndromes. Likewise, a circadian variation in anticoag-
ulant response to heparin has been reported with a peak effect between
00:00 and 04:00 and a nadir 08:00 to 12:00 hours. This contributes to vari-
ability in aPTI's and may be clinically important. predisposing to increased
thrombotic events in the morning and bleeding events at night. The reason
for this variation is unclear. TIMI-5 was a pilot trial of hirudin, a specific di-
rect thrombin inhibitor, with t-PA and aspirin in acute myocardial infarction.
To determine if a circadian variation in anticoagulant response to hirudin is
present, we examined aPTI results obtained using Ciba-Corning 512 monitor
every 12 hours during the 5-day constant infusion in 87 patients at 3 different
fixed infusion rates (0.05, 0.10,0.20 mg/kg/hr). Data for aPTIs drawn during
4 time periods are expressed in seconds: mean ± SD (# of aPTIs).
Hemorrhagic Stroke Associated with High aPTTs
Following Thrombolytic Therapy and Heparin or
Hirudin
Cristopher Granger, Frans Van de Wert, Mark Horrigan, Robert Califf,
Lynn WDodlief, Eric TDPDI, GUSTO Iia Investigators. Duke University Med,,:al Center,
Durham, NC
In GUSTO Ila, 2564 patients with acute coronary syndrome with ST devia-
tiDn and symptoms within 12 hours were randomized to hirudin (0.6 mg/kg
bolus, 0.6 mglkg/hr infusiDn with out adjustment) or IV heparin (5,000 U bo-
lus, 1100 to 1300 U/hr adjusted tD a target aPTF of 60-90 seconds) for 3-5
days. The 26 patients who suffered hemorrhagic stroke, as expected from
previous studies examining risk factors, were older (median age 71 vs 65).
had higher initial systolic blood pressure (142 vs 134 mmHg) and were more
commonly female (42 vs 31 %). Unexpectedly, hemorrhagic stroke patients
weighed more (82 vs 77 kg), which may have reflected weight-adjusted dos-
ing and consequent administration of more anticoagulant. Of the 26 patients,
23 were treated with thrombolytic therapy. In spite of concern over renal
dysfunction contributing to increased risk, the baseline and 48 hour creati-
nine was similar among hirudin treated patients with (1.2,1.21 and without
(1.1,1.1) hemorrhagic stroke. APTT was a predictor of hemorrhagic stroke,
particularly in the hirudin assigned group:
Multivariable analysis will help to determine the relative importance of risk
factors in GUSTO lIa for hemorrhagic stroke, and whether the elevated aPTTs
appear to fully explain the increased risk. These data illustrate the narroW
therapeutic window for antithrombin therapy in conjuction with thromboly-
sis.
